Vertex Pharmaceuticals Newsroom

Vertex Pharmaceuticals Analyst Ratings

BenzingaJul 11 13:11 ET

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $455 From $402

MT NewswiresJul 11 08:33 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 27 05:47 ET

Redburn Atlantic Initiates Vertex Pharmaceuticals at Buy With $545 Price Target

MT NewswiresJun 27 05:21 ET

Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $500 From $456, Maintains Overweight Rating

MT NewswiresJun 25 12:15 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 24 09:03 ET

Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $555 From $540

MT NewswiresJun 24 06:18 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 17 13:07 ET

Argus Adjusts Price Target on Vertex Pharmaceuticals to $550 From $465

MT NewswiresJun 17 07:57 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 11 07:37 ET

RBC Adjusts Price Target on Vertex Pharmaceuticals to $421 From $424

MT NewswiresJun 11 05:25 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 4 09:51 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaMay 31 09:42 ET

Wells Fargo Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TipRanksMay 28 06:48 ET

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH)

TipRanksMay 27 08:35 ET

Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497

MT NewswiresMay 14 05:48 ET

Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)

TipRanksMay 8 22:15 ET

Vertex Pharmaceuticals Sell Rating Maintained Amid Unsustainable Performance and Uncertain Pipeline Progress

TipRanksMay 8 07:36 ET

Sell Rating on Vertex Pharmaceuticals Amid Non-Recurring Gains and Overstated Sales

TipRanksMay 8 00:41 ET

Oppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)

TipRanksMay 7 08:20 ET